Citation Impact
Citing Papers
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein
2007 StandoutNobel
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice
2003
Contrast Medium-Induced Acute Kidney Injury
2015 Standout
Anti-C5a Ameliorates Coagulation/Fibrinolytic Protein Changes in a Rat Model of Sepsis
2002
The Role of Plasminogen-Plasmin System in Cancer
2009
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor
1995 StandoutNatureNobel
Prospects for Cardiovascular Research
2001 StandoutNobel
Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis
2013
Adrenergic Receptors From Molecular Structure to in vivo function
1997 StandoutNobel
Thrombin activatable fibrinolysis inhibitor (TAFI)—How does thrombin regulate fibrinolysis?
2006
TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation
2011
An update on bioactive plant lignans
2005 Standout
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Extracellular matrix structure
2015 Standout
Adrenergic receptor signal transduction and regulation
1995 StandoutNobel
Thrombin generation assays: accruing clinical relevance
2004
Mechanism of agonist and antagonist binding to .alpha.2 adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex
1988
Regulation of β-Adrenoceptors in a Rat Model of Cardiac Failure: Effect of Perindopril
1998
Unoccupied β-adrenoceptor-induced adenylyl cyclase stimulation in turkey erythrocyte membranes
1994
Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding
1999
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Pulmonary thromboembolism
2009
The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases
2009
Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development
2007 StandoutNobel
The role of inflammation in vascular diseases
2000
Enantioselective Synthesis of Di- and Tri-Arylated All-Carbon Quaternary Stereocenters via Copper-Catalyzed Allylic Arylations with Organolithium Compounds
2016 StandoutNobel
Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic
2012 Standout
Phosphine Organocatalysis
2018 Standout
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Catalytic Asymmetric Total Synthesis of (−)-Actinophyllic Acid
2016
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Works of Viveca Nerme being referenced
Spontaneous coupling of the beta-adrenergic receptor to Ns in mammalian cardiac membranes.
1986
The β1- and β2-adrenoceptor affinity of atenolol and metoprolol
1988
Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis
2005
Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold‐dependent mechanism
2004
PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood
1998
The Fab-fragment of a PAI-1 Inhibiting Antibody Reduces Thrombus Size and Restores Blood Flow in a Rat Model of Arterial Thrombosis
1997
Endogenous noradrenaline masks beta-adrenergic receptors in rat heart membranes via tight agonist binding
1985
Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma
2003
Local proCPU (TAFI) Activation during Thrombolytic Treatment in a Dog Model of Coronary Artery Thrombosis can be Inhibited with a Direct, Small Molecule Thrombin Inhibitor (Melagatran)
2002
Shallow agonist competition binding curves for beta-adrenergic receptors: the role of tight agonist binding.
1987